Synopsys, Inc. — Q1 FY2014 Form 10-Q
Business context and period. Synopsys supplies electronic design automation software, semiconductor IP, hardware, and related services. This unaudited report covers the three months ended January 31, 2014, compared with the three months ended January 31, 2013. The company reports as one operating segment.
Financial performance and position
| Metric | Q1 FY2014 | Q1 FY2013 / prior balance date |
|---|---|---|
| Revenue | $479.0 million | $475.1 million; up 1% |
| Gross profit / margin | $373.1 million / 77.9% | $364.1 million / 76.6% |
| Operating income / margin | $60.2 million / 12.6% | $61.0 million / 12.8% |
| Net income | $67.7 million | $69.9 million; down 3% |
| Diluted EPS | $0.43 | $0.45 |
| Cash from operations | $(73.9) million | $(91.4) million |
| Cash and cash equivalents | $893.1 million | $1,022.4 million at October 31, 2013 |
| Working capital | $284.2 million | $225.1 million at October 31, 2013 |
| Debt | $97.5 million term-loan balance; no revolver borrowings | $105.0 million term-loan balance at October 31, 2013 |
- Revenue mix: time-based licenses were $400.1 million, up 4% and 84% of revenue; upfront licenses were $34.0 million, up 10%; maintenance and services were $44.8 million, down 23%.
- Operating cash use improved year over year but remained negative, reflecting working-capital movements, including payments on liabilities and lower deferred revenue. Investing cash use was $9.4 million; financing cash use was $41.0 million, including $54.7 million of share repurchases.
- Cash was approximately $289.2 million in the U.S. and $603.9 million in foreign subsidiaries. The company said foreign funds were generally considered indefinitely reinvested; repatriation could entail additional U.S. taxes.
Material changes and management commentary
- Revenue was nearly flat: higher time-based and upfront license revenue was substantially offset by lower maintenance and professional-services revenue. The services decline primarily reflected project timing.
- Cost of revenue fell 5%, mainly because acquired intangible assets were fully amortized and certain prior-year inventory adjustments had ended. Gross margin improved, but operating income edged lower as total operating expenses rose 3%.
- Research and development expense increased 6%, primarily from higher headcount and personnel costs; sales and marketing rose 4%. General and administrative expense declined 10%.
- Other income included a $6.4 million gain from liquidation of a non-marketable investment. The effective tax rate was 4.9%, versus 2.5% a year earlier, reflecting in part the expiration of the federal research tax credit and prior-year tax items; the quarter also included an IRS settlement benefit.
- Management described the business outlook as solid, citing technology, customer relationships, the time-based revenue model, expense management, and acquisitions. It noted that time-based revenue generally represents about 90% of revenue and that current-period revenue often reflects prior-period sales. No specific forward revenue or earnings guidance was provided in the supplied filing text.
Outlook, risks, contingencies, and unusual items
- After quarter-end, Synopsys agreed to acquire Coverity for approximately $375 million in cash plus assumption of outstanding unvested stock options. Closing was expected in Q2 FY2014, funded with cash and debt. Management expected a short-term negative effect on net income and identified integration, retention, competition, and execution risks.
- The company said existing cash, operating cash generation, and available revolving credit were expected to meet routine business requirements for at least the next 12 months. Its $350 million revolving facility was undrawn; the credit agreement includes leverage and minimum-cash covenants.
- Gross unrecognized tax benefits were $115 million, excluding interest and penalties. The company said $0–$36 million could potentially decrease over the coming 12 months, though timing and settlement amounts were uncertain.
- One customer generated 11.6% of quarterly revenue. Key disclosed risks include semiconductor-industry and customer R&D-spending cycles, competition, revenue and renewal timing, acquisition execution, foreign currency exposure, tax uncertainty, intellectual-property disputes, and international operations.
- Routine legal proceedings continued. Mentor challenged the validity of a Synopsys patent in an inter partes review; separately, the PTO issued a decision finding some challenged claims of a Mentor patent valid and others invalid. The filing reported no material developments in previously disclosed proceedings.
- Disclosure controls were assessed as effective, and no material change in internal control over financial reporting was reported.
Key facts for investors to verify
- Whether the Coverity acquisition closed on expected terms and how its financing, integration, and earnings impact developed.
- Whether recurring time-based license growth can offset continued weakness or volatility in maintenance and services revenue.
- Drivers of negative quarterly operating cash flow and the sustainability of cash, working capital, and planned repurchases.
- Resolution and cash implications of uncertain tax positions, including the $115 million gross unrecognized tax benefits.
- Developments in patent disputes and the concentration of revenue in a single customer.